0 Comentários
0 Compartilhamentos
113 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Oncology Blockbuster Drugs Market Trends and Future Growth"What’s Fueling Executive Summary Oncology Blockbuster Drugs Market Size and Share Growth Global oncology blockbuster drugs market size was valued at USD 31.99 billion in 2024 and is projected to reach USD 63.49 billion by 2032, with a CAGR of 8.00% during the forecast period of 2025 to 2032. To stand apart from the competition, a careful idea about the competitive landscape,...0 Comentários 0 Compartilhamentos 824 Visualizações 0 Anterior
-
Oral Targeted Oncology Drug Market Report: Growth Analysis, Trends & Future Outlook"Executive Summary Oral Targeted Oncology Drug Market Market: Growth Trends and Share Breakdown The global oral targeted oncology drug market size was valued at USD 20.73 billion in 2025 and is expected to reach USD 43.47 billion by 2033, at a CAGR of 9.70% during the forecast period In this competitive marketplace, businesses are always in struggle to seek...0 Comentários 0 Compartilhamentos 252 Visualizações 0 Anterior
-
Precision Oncology Drug Portfolio Market Size, Industry Development and Forecast Insights"Executive Summary Precision Oncology Drug Portfolio Market Market: Share, Size & Strategic Insights The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period This Precision Oncology Drug Portfolio Market Market research...0 Comentários 0 Compartilhamentos 278 Visualizações 0 Anterior
-
Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...0 Comentários 0 Compartilhamentos 157 Visualizações 0 Anterior
-
5-Aminolevulinic Acid Hydrochloride (ALA) Market: Photodynamic Therapy Advancements, Dermatology and Oncology Applications, and Agricultural Biotechnology Trends"In-Depth Study on Executive Summary 5-Aminolevulinic Acid Hydrochloride (ALA) Market Size and Share Data Bridge Market Research analyses that the 5-aminolevulinic acid hydrochloride (ALA) market will witness a CAGR of 3.6% for the forecast period of 2022-2029 and is likely to reach at USD 1020 million by the end of the forecast period of 2022-2029. Trustworthy sources such as websites,...0 Comentários 0 Compartilhamentos 490 Visualizações 0 Anterior
-
Advancements in NK Cell Engineering and Bispecific Antibodies Driving the Market's Explosive Growth in Oncology.The enormous potential of **Natural Killer (NK) cell therapeutics** stems not just from the cells themselves but from technological breakthroughs in their engineering and strategic combination with other agents, most notably **bispecific antibodies**. The inherent limitations of unmodified NK cells—specifically their short lifespan, poor persistence *in vivo*, and difficulty penetrating...0 Comentários 0 Compartilhamentos 904 Visualizações 0 Anterior
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Comentários 0 Compartilhamentos 803 Visualizações 0 Anterior
-
Antibody Drug Conjugates (ADCs) Market to Witness Accelerated Growth Amid Rising Oncology InnovationsThe Antibody Drug Conjugates (ADCs) Market has moved from niche oncology innovation to one of the most closely watched segments in biopharmaceutical development. Once considered technically complex and commercially uncertain, ADCs now represent a validated therapeutic platform with multiple regulatory approvals and an expanding clinical pipeline. In simple terms, ADCs combine the...0 Comentários 0 Compartilhamentos 303 Visualizações 0 Anterior
-
Are Personalized Oncology Approaches Accelerating the Tumor Markers Testing Market?Key Drivers Impacting Executive Summary Tumor Markers Testing Market Size and Share CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The Tumor Markers Testing Market report contains market insights and analysis for Tumor...0 Comentários 0 Compartilhamentos 369 Visualizações 0 Anterior
-
Asia-Pacific Leads Injectable Device Expansion: Diabetes and Oncology Demand Push Regional Market to $22B by 2030, 10% CAGRThe Asia-Pacific (APAC) region is the fastest-growing segment of the injectable drug delivery devices market, outpacing North America and Europe with a projected 10% CAGR from 2024 to 2030. Valued at $12 billion in 2023, APAC’s regional market is expected to reach $22 billion by 2030, driven by rising chronic disease rates, expanding healthcare access, and a surge in biologic drug use....0 Comentários 0 Compartilhamentos 876 Visualizações 0 Anterior
-
Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine ApplicationsThe global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Anastrozole Tablets Market: Trends, Growth Drivers, and Competitive Analysis"In-Depth Study on Executive Summary Anastrozole Tablets Market Size and Share The global anastrozole tablets market size was valued at USD 410.71 million in 2025 and is expected to reach USD 512.25 million by 2033, at a CAGR of 2.80% during the forecast period The Anastrozole Tablets Market report has been designed by keeping in mind the customer...0 Comentários 0 Compartilhamentos 347 Visualizações 0 Anterior
-
Biosimilar Bevacizumab Market Poised for Robust Growth as Cost-Effective Oncology Therapies Gain TractionThe global Biosimilar Bevacizumab Market is on a robust growth trajectory, driven by the increasing demand for affordable cancer treatments, the expiration of patents on the reference biologic Avastin, and supportive regulatory frameworks. According to a comprehensive report by Market Research Future, the market was valued at USD 1.814 billion in 2024. It is projected to grow from USD...0 Comentários 0 Compartilhamentos 6 Visualizações 0 Anterior
-
Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...0 Comentários 0 Compartilhamentos 693 Visualizações 0 Anterior
-
Cell Cycle Inhibitors Market Advancing Targeted Cancer TreatmentsIn-Depth Study on Executive Summary Cell Cycle Inhibitors Market Size and Share CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. This Cell Cycle Inhibitors Market report is structured with the thorough market analysis carried...0 Comentários 0 Compartilhamentos 833 Visualizações 0 Anterior
-
Emerging Trends in the Oncology Device Market ResearchRecent Oncology Device Market research highlights the adoption of minimally invasive and personalized cancer treatment devices. Research shows that patient-centric innovations, such as wearable monitoring systems and precision radiotherapy devices, are improving outcomes while reducing treatment risks. Manufacturers are increasingly focusing on sustainable device designs and integration of...0 Comentários 0 Compartilhamentos 586 Visualizações 0 Anterior
-
Fluorescence Guided Surgery Systems Market to Grow at a CAGR of 16.30% Through 2032“According to a new report published by Introspective Market Research, Fluorescence Guided Surgery Systems Market by Product Type, Application, and End User, The Global Fluorescence Guided Surgery Systems Market Size Was Valued at USD 92.70 Billion in 2023 and is Projected to Reach USD 360.83 Billion by 2032, Growing at a CAGR of 16.30% from 2024 to 2032.” Fluorescence guided...0 Comentários 0 Compartilhamentos 468 Visualizações 0 Anterior
-
Gastroesophageal Junction Adenocarcinoma Therapeutics Market Overview, Growth Analysis, Trends and Forecast By 2032"Executive Summary Gastroesophageal Junction Adenocarcinoma Therapeutics Market : During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 17.56%, primarily driven by the rising prevalence and treatments advancements Gastroesophageal Junction Adenocarcinoma Therapeutics Market report provides the market potential for each geographical region...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek